News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioFactura Awarded US Patent for its StableFastTM Biomanufacturing Platform


11/22/2011 9:43:29 AM

ROCKVILLE, Md.--(BUSINESS WIRE)--BioFactura, Inc. was awarded a US patent covering the core technologies of its proprietary StableFastTM Biomanufacturing Platform. The US Patent and Trademark Office allowed 32 claims broadly covering composition of matter, methods, commercial kits, and media formulations. StableFastTM was commercially launched earlier this year. The Company is actively marketing the system to companies developing biopharmaceuticals including novel compounds and biosimilars with a focus on therapeutic monoclonal antibodies.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES